Factors that predict progression-free survival in Chinese lung adenocarcinoma patients treated with epidermal growth factor receptor tyrosine kinase inhibitors

BACKGROUND: Although first-generation epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) have shown efficacy in patients with advanced lung cancers, survival predictors with these drugs have not been extensively investigated. This study was performed to explore factors that may...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Thorac Dis
Hlavní autoři: Cui, Shaohua, Xiong, Liwen, Lou, Yuqing, Shi, Huangping, Gu, Aiqin, Zhao, Yizhuo, Chu, Tianqing, Wang, Huimin, Zhang, Wei, Dong, Lili, Jiang, Liyan
Médium: Artigo
Jazyk:Inglês
Vydáno: AME Publishing Company 2016
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4740173/
https://ncbi.nlm.nih.gov/pubmed/26904214
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2072-1439.2016.01.12
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky